TED Ted Baker Plc

    1 March 2005

                           Tepnel Life Sciences PLC                            

                   COMPANY STRATEGY Briefing, March 22nd2005                   

                     Advance notice of Preliminary Results                     

Manchester, UK. 1 March 2005* The Board of Tepnel Life Sciences' (AIM: TED) are
pleased to invite investors to their Company Strategy Briefing to be held on
22nd March 2005 from 11am - 12:30pm.

Venue: New Connaught Rooms, Covent Garden Exhibition Centre, 61-65 Great Queen
Street, London, WC2B 5DA

During this briefing the Company will present its preliminary results for year
ended 31 December 2004 together with a presentation on strategy and direction
for the future.

Any investor who would like to attend should contact:

Elni Stofberg, De Facto Communications (tel: +44 (0)207 940 1022), e-mail:
e.stofberg@defacto.com

                                    -ends-                                     

For Further Information:

Tepnel Life Sciences plc

Ben Matzilevich, CEO

Gron Ffoulkes-Davies, Finance Director

0161 946 2200

Seymour Pierce

Mark Percy, Corporate Finance

0207 107 8000

De Facto Communications

Richard Anderson

020 7940 1000

Notes to Editors

About Tepnel Life Sciences plc

Tepnel is a UK-based international life sciences instrumentation and services
company with a `tri-polar' strategy focused on providing the biomedical
industry with high-throughput automated DNA purification systems, manual DNA
purification kits and reagents, as well as scientific services for nucleic acid
purification, drug analysis, genotyping and genetically modified foods. Tepnel
was founded in 1992 to exploit DNA technology generated at UMIST (University of
Manchester Institute of Science and Technology) and is quoted on the AIM
segment of the London Stock Exchange (AIM: TED). More information on Tepnel can
be found at www.tepnel.com.



END

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024